VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
MMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
MMSMaximus, Inc.
$53.79$2.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMMSFinancials

Maximus, Inc. (MMS) Income Statement

30Y historyFree accessUpdated daily

Revenue declined 5.1% YoY in Q3 FY2026 to $1.3B, yet gross margin improved 230 basis points to 27.3% and EPS grew 4.8% to $1.95, indicating a favorable mix shift and cost controls.

Income StatementBalance SheetCash FlowRatios

MMS Income Statement

Annual statement

MMS Income Statement

Maximus, Inc. (MMS) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97Sep'96
Sales/Revenue5.25B5.43B5.31B4.9B4.63B4.25B3.46B2.89B2.39B2.45B2.4B2.1B1.7B1.33B1.05B929.63M831.75M717.3M745.13M738.65M700.89M647.54M603.77M558.28M518.7M487.26M399.16M319.5M233.5M127.9M103.1M
Revenue Growth %-3.32%2.36%8.19%5.91%8.85%22.91%19.91%20.67%-2.4%1.98%14.46%23.45%27.77%26.77%12.96%11.77%15.96%-3.74%0.88%5.39%8.24%7.25%8.15%7.63%6.45%22.07%24.93%36.83%82.56%24.05%-
Cost of Goods Sold3.97B4.19B4.15B3.97B3.78B3.35B2.79B2.29B1.81B1.85B1.85B1.6B1.25B945.25M762.2M675.98M610.92M525.03M543.39M561.56M547.54M467.59M427.21M391.71M357.04M335.83M269.61M222.5M170.5M93.8M78.1M
COGS % of Revenue-77.14%78.14%80.96%81.66%78.78%80.49%79.46%75.58%75.53%77.16%76.03%73.42%71%72.58%72.71%73.45%73.2%72.93%76.03%78.12%72.21%70.76%70.16%68.83%68.92%67.54%69.64%73.02%73.34%75.75%
Gross Profit1.28B1.25B1.16B934.02M849.35M902.62M675.37M592.93M584.08M599.7M548.81M503.37M452.12M386.03M287.94M253.65M220.83M192.27M201.74M177.08M153.35M179.95M176.57M166.58M161.66M151.43M129.55M97M63M34.1M25M
Gross Margin %24.38%23.01%21.86%19.04%18.34%21.22%19.51%20.54%24.42%24.47%22.84%23.97%26.58%29%27.42%27.29%26.55%26.8%27.07%23.97%21.88%27.79%29.24%29.84%31.17%31.08%32.46%30.36%26.98%26.66%24.25%
Gross Profit Growth %-7.74%24.2%9.97%-5.9%33.65%13.9%1.52%-2.6%9.27%9.03%11.33%17.12%34.07%13.52%14.86%14.86%-4.7%13.93%15.47%-14.78%1.92%6%3.04%6.75%16.89%33.56%53.97%84.75%36.4%-
Operating Expenses708.99M673.13M668.37M638.65M537.56M483.27M384.19M273.12M284.29M284.51M266.06M238.79M226.22M197.86M157.4M132.06M118.78M106.72M115.65M135.58M129.68M116.68M113.52M108.59M96.98M84.39M74.17M53.8M39.9M23.1M13.4M
OpEx % of Revenue-12.39%12.6%13.02%11.61%11.36%11.1%9.46%11.88%11.61%11.07%11.37%13.3%14.86%14.99%14.21%14.28%14.88%15.52%18.36%18.5%18.02%18.8%19.45%18.7%17.32%18.58%16.84%17.09%18.06%13%
Selling, General & Admin512.63M673.13M668.37M638.65M537.56M483.27M384.19M273.12M284.29M284.51M266.06M238.79M226.22M197.86M157.4M132.06M118.78M106.72M115.65M135.58M129.68M116.68M113.52M107.41M96.01M78.8M67.95M51.1M37.5M22.7M13.1M
SG&A % of Revenue-12.39%12.6%13.02%11.61%11.36%11.1%9.46%11.88%11.61%11.07%11.37%13.3%14.86%14.99%14.21%14.28%14.88%15.52%18.36%18.5%18.02%18.8%19.24%18.51%16.17%17.02%15.99%16.06%17.75%12.71%
Research & Development00000000000004.6M4.9M0000000000000000
R&D % of Revenue-------------0.35%0.47%----------------
Other Operating Expenses2M00000000000000000000001.19M968K5.6M6.22M2.7M2.4M400K300K
Operating Income570.7M576.75M491.72M295.37M311.78M419.35M291.18M319.81M299.78M315.19M282.75M264.58M225.9M188.17M130.54M121.59M102.06M85.54M86.09M41.5M23.68M63.27M63.05M57.04M64.34M67.04M55.38M43.2M23.1M11M11.6M
Operating Margin %10.87%10.62%9.27%6.02%6.73%9.86%8.41%11.08%12.53%12.86%11.77%12.6%13.28%14.13%12.43%13.08%12.27%11.93%11.55%5.62%3.38%9.77%10.44%10.22%12.4%13.76%13.88%13.52%9.89%8.6%11.25%
Operating Income Growth %-17.29%66.48%-5.26%-25.65%44.02%-8.95%6.68%-4.89%11.47%6.87%17.12%20.05%44.15%7.36%19.14%19.3%-0.64%107.45%75.28%-62.58%0.36%10.53%-11.34%-4.03%21.04%28.21%87.01%110%-5.17%-
EBITDA720.62M722.57M627.04M457.38M453.48M523.67M398.14M405.26M361.98M383.16M354.54M320.77M274.57M223.99M157M144.44M120.39M97.78M98.62M62.47M41.32M78.42M76.2M68.27M71.62M77.12M61.61M45.9M25.5M11.4M11.9M
EBITDA Margin %13.73%13.3%11.82%9.33%9.79%12.31%11.5%14.04%15.13%15.63%14.75%15.28%16.14%16.83%14.95%15.54%14.47%13.63%13.24%8.46%5.9%12.11%12.62%12.23%13.81%15.83%15.43%14.37%10.92%8.91%11.54%
EBITDA Growth %5.05%15.23%37.09%0.86%-13.4%31.53%-1.76%11.96%-5.53%8.07%10.53%16.83%22.58%42.67%8.7%19.97%23.13%-0.86%57.87%51.18%-47.31%2.92%11.61%-4.68%-7.13%25.18%34.22%80%123.68%-4.2%-
D&A (Non-Cash Add-back)149.93M145.82M135.33M162.02M141.69M104.32M106.96M85.46M62.19M67.98M71.78M56.2M48.67M35.82M26.46M22.84M18.34M12.23M12.53M20.97M17.64M15.14M13.15M11.23M7.28M10.08M6.22M2.7M2.4M400K300K
EBIT580.66M528.93M488.95M294.43M323.06M398.43M289.12M320.28M300.21M316.4M290.1M261.22M227.37M189.06M131.75M125.9M108.32M89.96M46.5M3.12M21.14M59.62M64.09M57.98M64.68M67.04M55.38M43.7M27.8M12.7M12.4M
Net Interest Income-89.24M-84.08M-82.44M-84.14M-45.97M-14.74M-2.06M-2.96M-1M-2.16M-4.13M-1.4M004.17M3.5M916K145K2.42M000000000000
Interest Income000000000000004.18M3.5M916K145K2.42M000000000000
Interest Expense89.24M84.08M82.44M84.14M45.97M14.74M2.06M2.96M1M2.16M4.13M1.4M004K0000000000000000
Other Income/Expense-79.27M-131.9M-85.21M-85.08M-34.69M-35.67M-4.12M-2.49M-574K-952K3.21M-4.76M1.47M885K1.21M4.3M6.27M4.42M-39.6M-38.38M-19.64M-3.65M1.04M1.38M3.1M1.51M-830K3.6M1.8M2.6M-100K
Pretax Income491.43M444.85M406.51M210.29M277.1M383.68M287.06M317.32M299.21M314.24M285.97M259.82M227.37M189.06M131.75M125.9M108.32M89.96M46.5M3.12M4.03M59.62M64.09M58.42M67.44M68.55M54.55M46.8M24.9M12M11.8M
Pretax Margin %9.36%8.19%7.66%4.29%5.98%9.02%8.29%10.99%12.51%12.82%11.9%12.37%13.37%14.2%12.55%13.54%13.02%12.54%6.24%0.42%0.58%9.21%10.61%10.46%13%14.07%13.67%14.65%10.66%9.38%11.45%
Income Tax120.54M125.81M99.59M48.5M73.27M92.48M72.55M76.83M78.39M102.05M105.81M99.77M81.97M71.93M55.65M43.75M38.92M35.38M18.22M11.37M1.57M23.55M25.32M23.08M27.09M28.45M24.09M19.2M10.4M3.4M200K
Effective Tax Rate %24.53%28.28%24.5%23.06%26.44%24.1%25.27%24.21%26.2%32.48%37%38.4%36.05%38.05%42.24%34.75%35.93%39.33%39.18%364.67%39%39.5%39.5%39.5%40.17%41.5%44.15%41.03%41.77%28.33%1.69%
Net Income370.89M319.03M306.91M161.79M203.83M291.2M214.51M240.82M220.75M209.43M178.36M157.77M145.44M116.73M76.13M81.17M70.41M46.54M6.68M-8.26M2.46M36.07M38.77M35.35M40.35M36.25M30.47M27.6M14.5M8.6M11.6M
Net Margin %7.07%5.87%5.78%3.3%4.4%6.84%6.2%8.34%9.23%8.54%7.42%7.51%8.55%8.77%7.25%8.73%8.47%6.49%0.9%-1.12%0.35%5.57%6.42%6.33%7.78%7.44%7.63%8.64%6.21%6.72%11.25%
Net Income Growth %17.28%3.95%89.7%-20.62%-30%35.75%-10.93%9.09%5.41%17.42%13.05%8.48%24.59%53.33%-6.2%15.28%51.29%597.02%180.88%-435.57%-93.18%-6.98%9.7%-12.39%11.31%18.96%10.39%90.34%68.6%-25.86%-
Net Income (Continuing)370.89M319.03M306.91M161.79M203.83M291.2M214.51M240.5M220.82M212.18M180.16M160.05M145.4M117.35M76.1M82.14M69.4M54.58M29.82M-8.26M2.46M36.07M38.77M35.35M40.35M40.1M30.47M27.6M15.5M9.5M11.8M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000409K2.55M5.68M4.06M3.32M223K267K00000000000000000
EPS (Diluted)6.995.514.992.633.294.673.393.723.353.172.692.352.111.671.091.140.980.650.09-0.090.030.420.440.420.430.400.360.330.210.160.39
EPS Growth %24.68%10.42%89.73%-20.06%-29.55%37.76%-8.87%11.04%5.68%17.84%14.47%11.37%26.35%53.21%-4.39%16.33%50.77%642.86%192.69%-443.27%-93.45%-4.55%4.76%-2.33%7.5%11.11%9.09%57.14%31.25%-58.97%-
EPS (Basic)-5.565.032.653.304.693.403.733.373.192.712.372.151.711.121.181.010.660.09-0.090.030.420.450.420.450.420.360.340.220.170.39
Diluted Shares Outstanding53.06M57.92M61.48M61.45M61.97M62.37M63.32M64.82M65.93M66.06M66.23M67.28M69.09M69.89M69.61M71.06M71.86M71.54M77.22M87.48M87.28M86.61M88.06M85.34M93.15M90.05M85.7M83.56M73.18M58.46M30M
Basic Shares Outstanding52.85M57.41M61.05M61.13M61.77M62.07M63.06M64.5M65.5M65.63M65.82M66.68M67.68M68.17M67.73M68.83M69.65M70.28M76.24M87.48M85.86M85.32M86.36M84M90.7M86.81M84.22M82.15M71.75M56.72M30M
Dividend Payout Ratio-21.54%23.75%42.07%33.71%23.64%32.7%26.53%5.3%5.57%6.56%7.56%8.38%10.51%16%12.72%11.89%17.31%116.79%-349.06%17.75%-----2.9%51.03%254.65%18.97%

Key Metrics

Growth RegimeStable
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Quarterly EPS miss and margin compression

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Stable Revenue Amidst Modest Decline

Revenue growth has turned slightly negative, with Q3 FY2026 down 5.1% YoY, though the 2.36% annual growth suggests a plateau rather than a downturn, per recent filings.

The quarterly revenue decline of 5.1% in Q3 FY2026, following a 4.1% drop in Q2, indicates a deceleration from the mid-single-digit growth seen in FY2024. This appears to reflect the winding down of pandemic-era Medicaid continuous enrollment volumes, which had boosted eligibility work. The stability of the annual growth rate suggests the company is transitioning to a more normalized demand environment, but investors should monitor whether this trend persists or stabilizes.

Gross Margin Expansion Despite Revenue Dip

Gross margin improved to 27.3% in Q3 FY2026, up from 25.0% a year earlier, suggesting a favorable mix shift or cost controls, as reported in the income statement.

The sequential and year-over-year gross margin expansion, from 23.2% in Q2 FY2026 to 27.3% in Q3, is notable given the revenue decline. This may indicate a shift toward higher-margin federal services or improved pricing on state contracts. However, the operating margin of 12.6% in Q3, while above the 10.6% average, remains below the peak of 12.3% seen in Q3 FY2025, suggesting that SG&A costs are absorbing some of the gross margin gains.

Operating Leverage Tempered by SG&A

Operating income grew 2.6% YoY in Q3 FY2026 despite a 5.1% revenue decline, indicating positive operating leverage, but SG&A as a percentage of revenue rose to 13.4% from 12.7% a year ago.

The ability to grow operating income on lower revenue suggests that the company is managing its cost structure effectively, likely through labor utilization improvements. However, the increase in SG&A intensity, from 12.7% to 13.4% of revenue, implies that overhead costs are not scaling down proportionally with revenue. This could be due to investments in growth initiatives or fixed costs that are difficult to adjust in the short term.

EPS Growth Outpacing Net Income

Diluted EPS grew 4.8% YoY in Q3 FY2026 to $1.95, while net income rose only 2.3%, indicating a lower share count or favorable tax effects, based on reported figures.

The divergence between EPS growth and net income growth suggests that the company may be repurchasing shares or benefiting from a lower effective tax rate. However, the Q3 FY2026 EPS of $1.95 missed the consensus estimate of $2.31, which may indicate a one-time charge or a mix shift that reduced profitability. Investors should scrutinize the quality of earnings, particularly the impact of stock-based compensation, which was $17.3M in Q3, up from $10.7M a year earlier.

COGS Efficiency Drives Margin Gains

COGS as a percentage of revenue fell to 72.7% in Q3 FY2026 from 75.0% a year earlier, a 230 basis point improvement, according to the income statement data.

The reduction in COGS intensity is a positive sign, suggesting that the company is achieving better labor productivity or passing through cost increases. However, SG&A expenses rose to $173.5M in Q2 FY2026, the highest in the period, indicating that overhead costs are not being controlled as tightly. The combination of lower COGS and higher SG&A suggests a shift in cost structure, possibly toward more technology investments or sales and marketing efforts.

FY2025 Q1 Marked a Profitability Trough

Net margin hit a low of 2.9% in Q1 FY2025, with EPS of $0.69, before recovering to 8.1% by Q3 FY2026, indicating a significant operational turnaround, as per financial statements.

The Q1 FY2025 quarter appears to be an inflection point, where net income was depressed by $41.2M, likely due to one-time charges or a contract ramp-up. Since then, margins have steadily improved, with net margin reaching 8.1% in Q3 FY2026. This recovery suggests that the company has successfully navigated a difficult period and is now operating at a more normalized level. The lasting impact is a more resilient cost structure, but the sustainability of this margin level depends on maintaining contract pricing and controlling labor costs.

Margin Compression Risk from Labor Costs

Despite recent margin gains, the Q3 FY2026 EPS miss of $0.36 versus consensus suggests potential cost overruns or mix shifts that could pressure future profitability, per reported results.

The significant EPS miss, despite maintained guidance, raises questions about the reliability of quarterly estimates and the potential for margin compression. The company's high-variable cost structure, dominated by labor, makes it vulnerable to wage inflation, especially in fixed-price contracts. If the revenue decline continues, the operating leverage could reverse, leading to margin contraction. Investors should monitor the company's ability to pass through cost increases and the trajectory of SG&A expenses, which have been rising.

MMS — Frequently Asked Questions

Quick answers to the most common questions about buying MMS stock.

What was Maximus, Inc.'s (MMS) revenue in 2025?

For fiscal year 2025, Maximus, Inc. (MMS) reported total revenue of $5.43B. This represents a 5168.0% increase compared to $103.1M in 1996.

Is Maximus, Inc. (MMS) profitable?

Maximus, Inc. (MMS) is profitable, generating $319.0M in net income for the fiscal year ending 2025 with a net profit margin of 5.9%.

What is Maximus, Inc.'s operating profit margin?

Maximus, Inc. (MMS) reported an operating income of $576.8M, resulting in an operating profit margin of 10.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Maximus, Inc.'s gross profit and gross margin?

Maximus, Inc. (MMS) generated $1.25B in gross profit for the year, representing a gross profit margin of 23.0%. This demonstrates the company's core pricing power and production efficiency.